Actinium Pharmaceuticals, Inc. (ATNM) and SCYNEXIS, Inc. (SCYX) Activist Update

Retrieved on: 2018-03-13 09:30:00

Tags for this article:

SEC filings

Ion Media

Pershing Square Capital Management

Actinium Pharmaceuticals Inc.

Click the tags to see associated articles and topics

Actinium Pharmaceuticals, Inc. (ATNM) and SCYNEXIS, Inc. (SCYX) Activist Update. View article details on hiswai:

Excerpt

<div>Autoliv, Inc. (ALV) – Cevian Capital II GP LTD has filed an amended Schedule 13D/A, reporting a 7.50% ownership stake in Autoliv. <b>Alteryx Inc</b>. (AYX) – Insight Venture Partners VIII, L.P. has filed an amended Schedule 13D/A, reporting a 33.40% ownership stake in Alteryx. This is a decrease of 9.24% ...</div>

Article found on:

View Original Article